Using light and AI to find cancer early
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial uses a special light-based test and artificial intelligence to detect several types of cancer early. It aims to see if this method can accurately identify cancer or precancerous changes before any treatment starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of one of these cancers: colorectal, stomach, liver, pancreas, or esophagus.
- You may also join if you are a healthy person without any cancer or precancerous conditions.
- You may join if you have a precancerous condition or a non-cancerous disease.
- You cannot have received any cancer treatments like chemotherapy, surgery, radiation, or immunotherapy before this test.
- You cannot have cancer that has spread to other parts of the body or have two or more types of cancer at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to use medical images, records, and other information to better assess cancer risk and guide treatment. It may be a good fit if you have a suspicious spot in your lungs, stomach, or colon, or if you are healthy and want to help with early cancer detection research.
This trial tests a new blood test that may find early signs of cancer in people who have no symptoms. If you join, you'll have a blood draw, and the study will check if the test can catch cancer early.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This trial uses a special light-based scanner (OCT) and artificial intelligence to help diagnose early signs of mouth cancer or precancer. It aims to see if this combination can make diagnosis easier and more accurate.
This study is testing whether an artificial intelligence system can find very small amounts of leftover cancer (minimal residual disease) after treatment for rectal or esophageal cancer. If successful, this could help doctors detect a relapse earlier than current methods.
Hear when a new Cancer Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.